Commentary
Clinical Pharmacology & Therapeutics (2007) 81, 26–28. doi:10.1038/sj.clpt.6100061
Gene mutations, atrial fibrillation, and the elusive cigar
J F Carlquist1 and J L Anderson1
1Division of Cardiology, Department of Medicine, University of Utah School of Medicine, Cardiovascular Department, LDS Hospital, Salt Lake City, Utah, USA
Correspondence: JL Anderson, John.Carlquist@intermountainmail.org
Abstract
Atrial fibrillation (AF) is the most common cardiac arrhythmia. The term lone AF describes nonsyndromic atrial fibrillation that occurs in the absence of underlying structural heart disease or predisposing clinical conditions. A hereditable component leading to conduction abnormalities in AF has long been suspected, and epidemiological evidence of elevated risk for AF among first-degree relatives of probands was recently documented.1 The first AF-associated molecular defect was found in an affected Chinese family; initial studies narrowed the chromosomal location by linkage analysis, and Yihan Chen et al.2 found a specific gain-of-function mutation in KCNQ1, the gene for the
subunit of potassium channels.
